Abstract

ObjectiveTo assess whether the mortality and morbidity risks vary with birth weight standard deviation score (BWSDS) in growth restricted extremely preterm infants. Study designThis was a multicenter retrospective cohort study using the database of the Neonatal Research Network of Japan and including 9149 infants born between 2003 and 2010 at <28weeks gestation. According to the BWSDSs, the infants were classified as: <−2.0, −2.0 to −1.5, −1.5 to −1.0, −1.0 to −0.5, and ≥−0.5. Infants with BWSDS≥−0.5 were defined as non-growth restricted group. ResultsAfter adjusting for covariates, the risks of mortality and some morbidities were different among the BWSDS groups. Compared with non-growth restricted group, the adjusted odds ratio (aOR) for mortality [aOR, 1.69; 95% confidence interval (CI), 1.35–2.12] and chronic lung disease (CLD) (aOR, 1.28; 95% CI, 1.07–1.54) were higher among the infants with BWSDS −1.5 to <−1.0. The aOR for severe retinopathy of prematurity (ROP) (aOR, 1.36; 95% CI, 1.09–1.71) and sepsis (aOR, 1.72; 95% CI, 1.32–2.24) were higher among the infants with BWSDS −2.0 to <−1.5. The aOR for necrotizing enterocolitis (NEC) (aOR, 2.41; 95% CI, 1.64–3.55) was increased at a BWSDS<−2.0. ConclusionBeing growth restricted extremely preterm infants confer additional risks for mortality and morbidities such as CLD, ROP, sepsis and NEC, and these risks may vary with BWSDS.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.